about
The Spectrum and Clinical Significance of Autoantibodies in Rheumatoid ArthritisInfluence of genetic polymorphisms (IL-10/CXCL8/CXCR2/NFκB) on the susceptibility of autoimmune rheumatic diseasesImpact on the Quality of Life of an Educational Program for the Prevention of Work-Related Musculoskeletal Disorders: a randomized controlled trialSafety of tocilizumab in the treatment of juvenile idiopathic arthritis.The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional studyMultinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in tClinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study.Is ultrasound a better target than clinical disease activity scores in rheumatoid arthritis with fibromyalgia? A case-control study.The paradox of high availability and low recognition of soluble HLA-G by LILRB1 receptor in rheumatoid arthritis patients.Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.Raised serum S100B protein levels in neuropsychiatric lupus.Effect of pegylated phosphatidylserine-containing liposomes in experimental chronic arthritisEffect of antioxidant treatment on fibrogenesis in rats with carbon tetrachloride-induced cirrhosis.Diminished expression of complement regulatory proteins on peripheral blood cells from systemic lupus erythematosus patients.The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia.Matrix metalloproteinase gene polymorphisms and susceptibility to systemic sclerosis.Two-Year Safety and Efficacy Experience in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis Treated with Etanercept and Conventional Disease-Modifying Anti-rheumatic Drugs in the Latin American Region.The role of mannose-binding lectin in systemic lupus erythematosus.Redox signalling and the inflammatory response in rheumatoid arthritis.Effect of Aqueous Extract of Giant Horsetail (Equisetum giganteum L.) in Antigen-Induced ArthritisNitric oxide and repair of skeletal muscle injury.Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study.Metabolic syndrome and juvenile idiopathic arthritis.Algorithm for identification of undifferentiated peripheral inflammatory arthritis: a multinational collaboration through the 3e initiative.Rheumatoid arthritis and metabolic syndrome.Autoimmune rheumatic diseases and their association with killer immunoglobulin-like receptor genes.The role of the HLA-G gene and molecule on the clinical expression of rheumatologic diseases.Mechanisms of muscle wasting in sarcopenia.Vitamin D and polymorphisms of VDR gene in patients with systemic lupus erythematosus.The role of complement regulatory proteins in peripheral blood cells of patients with systemic lupus erythematosus: review.Assessing rheumatoid arthritis disease activity with ultrasound.Electroconvulsive therapy as a treatment for refractory neuropsychiatric lupus with catatonia: three case studies and literature review.Update on the 2012 Brazilian Society of Rheumatology Guidelines for the treatment of rheumatoid arthritis: position on the use of tofacitinib.Gastrin-releasing peptide and its receptor increase arthritis fibroblast-like synoviocytes invasiveness through activating the PI3K/AKT pathway.Deletion of eIF2β lysine stretches creates a dominant negative that affects the translation and proliferation in human cell line: A tool for arresting the cell growth.Long-term outcomes of treat-to-target strategy in established rheumatoid arthritis: a daily practice prospective cohort study.Rheumatoid arthritis seems to have DMARD treatment decision influenced by fibromyalgia.Evaluation of polymorphic variants in apoptotic genes and their role in susceptibility and clinical progression to systemic lupus erythematosus.The role of BsmI and FokI vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D in Brazilian patients with systemic lupus erythematosus.Ficolin Gene Polymorphisms in Systemic Lupus Erythematosus and Rheumatoid Arthritis.
P50
Q27023858-179DC87A-11DF-4107-84D5-792964B72221Q28086939-AAF4B455-A0A8-4B06-8CE0-9719864F681BQ28386157-907BB943-1B71-4D2D-B90E-30F6B6E8D1B7Q30235357-1AFE90A8-FAD1-44BC-9108-98EFB0202134Q33610284-16E60E6C-495C-44BB-8A85-CCCCB5332E3DQ33610284-5DC716FB-54DC-4787-9AB9-B6F0B1CBBFEFQ33665938-164B1653-4F5C-4428-86FE-E098CBA31AD5Q34818996-6A0A919C-145D-467A-8099-0615A66CA753Q35147579-4F70E586-BD3D-4E58-9B0A-A6D21CBF9665Q35325312-CBB0D6FB-1A5A-4589-A35B-DE706A2D4B36Q35605487-87F816FD-9F21-4C09-898E-848CCB19E372Q35637257-4ECB5FA1-ED94-4F93-ABF9-D282D9DD44B0Q35782769-6686C5A3-EDCB-4E1B-A224-4EDC3243E000Q35909082-10D393AB-535B-4530-BF17-2D7D0DC3725AQ36065619-D2BC3219-59E5-4E10-8EAA-DBE83615315BQ36153480-6DC4D965-C6B9-4D3C-A8AC-43509E184E79Q36230610-05075C7C-E645-4A2D-8DCE-A8BA2A305BE7Q36658514-2E549D7F-86D2-4550-A1A3-03C93FC9787AQ37063384-730B3C76-4A7A-4E4F-8611-4DB32C0E9B04Q37142186-924F3367-98E5-4196-8815-5A51AADC4B5EQ37536644-B445D6C1-DE34-4432-870F-7AF141C02756Q37580125-9EB60E4C-9BD0-46A9-9823-891BBE859D6CQ37715956-8B91FA2A-E2A0-47A6-8023-576C6C6F3BCEQ37815009-AC8FD046-A0F4-43F7-8AD2-73AF890819BFQ37848577-C1FAAF2A-84EF-4690-970F-E528AB3F2E2EQ37882443-CFEDC49C-342A-4298-ACF5-CD8A3128C56DQ37903731-EB4997F4-99C4-44BA-B37F-432CF677E887Q37979683-9A4BF0B5-2516-48EF-A707-F9393B59DCFFQ37998359-B1B45642-8A42-4BDF-8D80-012A32AF9895Q38018250-8FCC1C78-A16B-4195-8E61-354F78EC8DA5Q38026309-E472C95D-652E-4839-93A4-E12374BFC4F5Q38108735-494B61C1-3A22-42E0-A9D9-3459621DDC8EQ38478619-9D2B9D16-881A-4714-B984-188ECB4C9B27Q38604390-E36B6E53-02BC-4088-A68F-6DA34A971A1AQ38667447-88625526-0D2F-4777-8256-E2320F0C6FB1Q38697728-EC7DC8AA-149B-448B-BB9A-11FF74CC30DFQ38907907-814829B0-C777-404F-B75D-AE75D8AA5277Q39046706-D3A3E982-6158-476B-AC78-626596DEF529Q39137962-CD20C49D-61A8-42F3-BDB0-1F533F22695AQ39698157-482592A5-BD69-49D4-8C44-17C1646FA6E4
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ricardo Machado Xavier
@ast
Ricardo Machado Xavier
@en
Ricardo Machado Xavier
@es
Ricardo Machado Xavier
@nl
Ricardo Machado Xavier
@sl
type
label
Ricardo Machado Xavier
@ast
Ricardo Machado Xavier
@en
Ricardo Machado Xavier
@es
Ricardo Machado Xavier
@nl
Ricardo Machado Xavier
@sl
prefLabel
Ricardo Machado Xavier
@ast
Ricardo Machado Xavier
@en
Ricardo Machado Xavier
@es
Ricardo Machado Xavier
@nl
Ricardo Machado Xavier
@sl
P106
P1153
7006636651
P21
P31
P496
0000-0001-6570-4533
P569
2000-01-01T00:00:00Z